USANA Health Sciences Director Sells Over $17K in Shares
Gilbert Fuller, a director at the nutritional supplements company, disclosed the sale of 1,058 shares.
Hudson Bay Capital Management Buys Stake in Zions Bancorporation
Institutional investor takes position in regional bank stock
Par Pacific CEO Sells $5.9M in Stock
William Monteleone sold over 108,000 shares of the company's stock.
Mar. 17, 2026
Algert Global Boosts Stake in Zions Bancorporation
Investment firm increases holdings in Utah-based regional bank by 22.9% in Q3
Mar. 16, 2026
Brevan Howard Reduces Stake in Zions Bancorporation
Hedge fund cuts holdings in Utah-based bank by 18.4% in Q3
Mar. 16, 2026
Health Catalyst Sees Increased Investment from First Light Asset Management
Institutional investor raises stake in healthcare data and analytics company
Mar. 14, 2026
Wall Street Zen Upgrades Par Pacific (NYSE:PARR) to Strong-Buy
Analysts raise rating on energy company's stock
Mar. 13, 2026
Citigroup Lowers Health Catalyst Price Target
Analysts cut price target for healthcare data and analytics company to $1.75
Mar. 12, 2026
Brean Capital Starts Coverage on Zions Bancorporation, N.A.
The firm set a "neutral" rating on the bank's stock.
Mar. 12, 2026
Barclays Increases Stake in Par Pacific Holdings
Investment firm boosts ownership in energy company by nearly 25%
Mar. 11, 2026
Barclays Increases Stake in Zions Bancorporation
Investment firm boosts holdings in Utah-based bank by 20.4% in Q3
Mar. 11, 2026
Natixis Advisors Increases Stake in Zions Bancorporation
Hedge fund boosts position in Utah-based bank by nearly 15% in Q3
Mar. 8, 2026
American Century Companies Boosts Stake in Zions Bancorporation
Investment firm increases holdings in regional bank by 13.4% in Q3
Mar. 8, 2026
Dynamic Technology Lab Private Ltd Takes Position in Par Pacific Holdings, Inc.
The investment firm purchased over 41,000 shares of the energy company's stock.
Mar. 4, 2026
Par Pacific Hits New 52-Week High, Analysts Weigh In
Refiner Par Pacific sees stock price surge, but analysts have mixed views on whether it's still a buy.
Mar. 3, 2026
USANA Health Sciences Provides FY 2026 Earnings Guidance
The company expects earnings per share between $1.95 and $2.29 on revenue of $925 million to $1 billion.
Mar. 3, 2026
Vanguard Group Boosts Stake in Par Pacific Holdings
Investment firm increases ownership in energy company by over 30%
Mar. 3, 2026
Advanced Deposition Technologies and Rogers Compared in Financial Analysis
Analysts say Rogers is the better stock pick over Advanced Deposition Technologies
Mar. 3, 2026
Par Pacific Downgraded to 'Buy' by Wall Street Zen
Analysts cite concerns over the company's refining and marketing operations.
Mar. 3, 2026
Intech Investment Management Boosts Par Pacific Holdings Stake
Asset manager increases ownership in energy company by 142.7% in Q3
Mar. 2, 2026
Rafferty Asset Management Trims Stake in Zions Bancorporation
The fund reduced its position in the bank's stock by 18.8% in the third quarter.
Mar. 2, 2026
Morgan Stanley Upgrades Zions Bancorporation to 'Overweight'
Analysts raise price target to $75 from $70 for the Utah-based bank holding company.
Feb. 28, 2026
Primecap Management Co. CA Trims Stake in Health Catalyst
Institutional investor reduces holding in healthcare data analytics firm
We keep track of fun holidays and special moments on the cultural calendar — giving you exciting activities, deals, local events, brand promotions, and other exciting ways to celebrate.
